President and CEO
@David Skorton, MD, and Chief Public Policy Officer
@Karen Fisher, JD, issued a statement on the introduction of the Substance Use Disorder Workforce Act in the U.S. House of Representatives, which would help support new residency positions to improve patient access to care and help address the substance use disorder epidemic. “The AAMC applauds Representatives Brad Schneider (D-Ill.), David McKinley (R-W.V.), and Annie Kuster (D-N.H.), for introducing bipartisan legislation to address the overwhelming impact of the substance use disorder crisis in the United States. The Substance Use Disorder Workforce Act would provide 1,000 new Medicare-supported graduate medical education training positions over five years in hospitals that have or are establishing accredited residency programs in addiction medicine, addiction psychiatry, or pain medicine.”